Pharmacology and Therapeutics

A systematic review and meta-analysis to evaluate the clinical outcomes in COVID -19 patients on angiotensin converting enzyme inhibitors or angiotensin receptor blockers
Abhinav Grover, Mansi Oberoi

medRxiv 2020.04.29.20085787; doi: https://doi.org/10.1101/2020.04.29.20085787

Add to Selected Citations
Assessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis
Lu Ren, Wilson Xu, James L Overton, Shandong Yu, Nipavan Chiamvimonvat, Phung N Thai

medRxiv 2020.05.02.20088872; doi: https://doi.org/10.1101/2020.05.02.20088872

Add to Selected Citations
MTXPK.org: A clinical decision support tool evaluating high-dose methotrexate pharmacokinetics to inform post-infusion care and use of glucarpidase
Zachary L Taylor, Tomoyuki Mizuno, Nieko Punt, Balaji Baskaran, Adriana Navarro Sainz, William Shuman, Nicholas Felicelli, Alexander A Vinks, Jesper Heldrup, Laura B Ramsey

medRxiv 2020.04.08.20056713; doi: https://doi.org/10.1101/2020.04.08.20056713

Add to Selected Citations
Efficacy and safety of antidepressants for the treatment of low back pain and osteoarthritis: protocol for a systematic review and meta-analysis
Giovanni Ferreira, Chung-Wei Christine Lin, Joshua R Zadro, Mary O'Keeffe, Christina Abdel Shaheed, Andrew McLachlan, Chris G Maher

medRxiv 2020.04.30.20086827; doi: https://doi.org/10.1101/2020.04.30.20086827

Add to Selected Citations
Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: an Exploratory Randomized, Controlled Trial
Yan Lou, Lin Liu, Yunqing Qiu

medRxiv 2020.04.29.20085761; doi: https://doi.org/10.1101/2020.04.29.20085761

Add to Selected Citations
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19
Virginia D Schmith, Jie Zhou, Lauren RL Lohmer

medRxiv 2020.04.21.20073262; doi: https://doi.org/10.1101/2020.04.21.20073262

Add to Selected Citations
Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics
Usman Arshad, Henry Pertinez, Helen Box, Lee Tatham, Rajith KR Rajoli, Paul Curley, Megan Neary, Joanne Sharp, Neill J Liptrott, Anthony Valentijn, Christopher David, Steve P Rannard, Paul O'Neill, Ghaith Aljayyoussi, Shaun Pennington, Stephen A Ward, David J Back, Saye H Khoo, Patrick G Bray, Giancarlo Biagini, Andrew Owen

medRxiv 2020.04.16.20068379; doi: https://doi.org/10.1101/2020.04.16.20068379

Add to Selected Citations
A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with coronavirus disease 2019（COVID-19）
Ming Zhong, Aijun Sun, Ting Xiao, Ge Yao, Ling Sang, Xia Zheng, Jinyan Zhang, Xuejuan Jin, Lei Xu, Wenlong Yang, Peng Wang, Kai Hu, Dingyu Zhang, Junbo Ge

medRxiv 2020.04.15.20066266; doi: https://doi.org/10.1101/2020.04.15.20066266

Add to Selected Citations
Dangers of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence
Krishna Sriram, Paul A. Insel

medRxiv 2020.03.25.20043927; doi: https://doi.org/10.1101/2020.03.25.20043927

Add to Selected Citations
Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials
Jing Wang, Li Yu, Kefeng Li

medRxiv 2020.04.13.20064295; doi: https://doi.org/10.1101/2020.04.13.20064295

Add to Selected Citations

Pharmacology and Therapeutics

Pages